Arterra Bioscience S.p.A. (BIT:ARBS)
Italy
· Delayed Price · Currency is EUR 3.040
+0.080 (2.70%)
Dec 5, 2025, 5:21 PM CET
Arterra Bioscience Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Net Income | 1.34 | 1.08 | 1.41 | 1.11 | 1.11 | Upgrade
|
| Depreciation & Amortization | 0.34 | 0.53 | 0.53 | 0.49 | 0.4 | Upgrade
|
| Other Amortization | 0 | - | - | - | - | Upgrade
|
| Other Operating Activities | 0.29 | -0.34 | 0.14 | -0.03 | 0.02 | Upgrade
|
| Change in Accounts Receivable | 0.05 | -0.18 | 0.29 | -0.76 | 0.07 | Upgrade
|
| Change in Inventory | 0.03 | -0.2 | -0.67 | 0.08 | -0.14 | Upgrade
|
| Change in Accounts Payable | 0.03 | 0.06 | -0.06 | 0.06 | -0.31 | Upgrade
|
| Change in Other Net Operating Assets | -1 | 0.07 | -0.25 | 0.44 | -0.67 | Upgrade
|
| Operating Cash Flow | 1.06 | 1.03 | 1.4 | 1.4 | 0.48 | Upgrade
|
| Operating Cash Flow Growth | 3.73% | -26.48% | -0.11% | 191.10% | -72.34% | Upgrade
|
| Capital Expenditures | -0.64 | -0.07 | -0.09 | -0.54 | -0.34 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.05 | 0.02 | 0.04 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.02 | -0.02 | -0 | -0.07 | -0.04 | Upgrade
|
| Investment in Securities | -0.1 | -0.77 | -1.63 | -0.5 | - | Upgrade
|
| Investing Cash Flow | -0.71 | -0.84 | -1.69 | -1.11 | -0.38 | Upgrade
|
| Short-Term Debt Issued | 0.03 | 0.1 | - | 0 | 0 | Upgrade
|
| Total Debt Issued | 0.03 | 0.1 | - | 0 | 0 | Upgrade
|
| Short-Term Debt Repaid | - | - | -0.04 | - | - | Upgrade
|
| Long-Term Debt Repaid | -0.06 | -0.2 | -0.08 | -0.2 | -0.19 | Upgrade
|
| Total Debt Repaid | -0.06 | -0.2 | -0.13 | -0.2 | -0.19 | Upgrade
|
| Net Debt Issued (Repaid) | -0.03 | -0.1 | -0.13 | -0.19 | -0.19 | Upgrade
|
| Issuance of Common Stock | - | - | - | 0.18 | 0.08 | Upgrade
|
| Repurchase of Common Stock | - | -0.13 | - | - | -0.11 | Upgrade
|
| Common Dividends Paid | -0.67 | -0.67 | - | - | - | Upgrade
|
| Financing Cash Flow | -0.7 | -0.89 | -0.13 | -0.01 | -0.23 | Upgrade
|
| Net Cash Flow | -0.34 | -0.71 | -0.42 | 0.28 | -0.13 | Upgrade
|
| Free Cash Flow | 0.42 | 0.96 | 1.3 | 0.86 | 0.14 | Upgrade
|
| Free Cash Flow Growth | -55.88% | -26.22% | 51.99% | 521.51% | -84.53% | Upgrade
|
| Free Cash Flow Margin | 10.15% | 28.77% | 36.23% | 18.05% | 3.30% | Upgrade
|
| Free Cash Flow Per Share | 0.06 | 0.14 | - | - | - | Upgrade
|
| Cash Income Tax Paid | 0.31 | 0.59 | 0.38 | 0.16 | 0.09 | Upgrade
|
| Levered Free Cash Flow | -0.25 | 0.5 | 1.27 | 0.43 | -0.26 | Upgrade
|
| Unlevered Free Cash Flow | -0.24 | 0.5 | 1.27 | 0.44 | -0.25 | Upgrade
|
| Change in Working Capital | -0.9 | -0.25 | -0.69 | -0.17 | -1.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.